Also mentions Nasdaq:
NASDAQ OMX Reports Record Fourth Quarter 2013 Results
x hide permanently

Corbus Pharmaceuticals Appoints George Golumbeski, Ph.D., to Board of Directors


Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system (ECS), today announced the appointment of George Golumbeski, Ph.D., to its Board of Directors...

Mentions: Nasdaq Target Corbus Pharmaceuticals Holdings, Inc.